So-Young International Inc. Sponsored ADR SY
- Market cap
- $229.5M
- P/E
- 0.0×
Follow SY
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | 8.38 | 8.03 | 2.93 | 0.50 | 0.83 | 0.66 | 0.67 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | 22.80 | 16.95 | 17.40 | 3.34 | 3.07 | 1.42 | 6.28 |
High Price
|
|||
| — | — | 862 | 1,218 | 1,564 | 2,085 | 1,573 | 1,357 | 1,800 | 2,348 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 7 | 38 | 90 | 165 | 198 | 266 | 182 | 211 | 201 | 218 |
Revenue
|
|||
| 48.68% | 82.72% | 85.17% | 82.75% | 83.61% | 80.63% | 68.73% | 63.66% | 61.30% | 47.77% |
Gross Margin
|
|||
| (11) | 3 | 8 | 33 | 0 | (3) | (13) | 1 | (81) | (35) |
EBT
|
|||
| (151.53%) | 6.58% | 9.44% | 19.66% | 0.01% | (0.97%) | (6.92%) | 0.53% | (40.10%) | (16.16%) |
EBT Margin
|
|||
| (15) | 0 | 8 | 25 | 1 | (6) | (10) | 4 | (80) | (35) |
Net Income
|
|||
| 0 | 0 | 0 | 1 | 2 | 5 | 7 | 6 | 6 | 8 |
Depreciation
|
|||
| 0.07 | 0.38 | 4.75 | 2.14 | 3.16 | 2.50 | 1.70 | 2.11 | 1.95 | 2.15 |
Revenue/Sh
|
|||
| (0.20) | (0.02) | 0.42 | 0.24 | 0.01 | (0.01) | (0.09) | 0.03 | (0.78) | (0.34) |
Earnings/Sh
|
|||
| (0.06) | 0.13 | 1.53 | 0.71 | 0.44 | 0.12 | (0.15) | 0.03 | (0.03) | (0.15) |
Cash Flow/Sh
|
|||
| 0.00 | 0.00 | (0.05) | (0.07) | (0.09) | (0.07) | (0.02) | (0.07) | (0.08) | (0.28) |
Capex/Sh
|
|||
| (0.06) | 0.13 | 1.49 | 0.64 | 0.35 | 0.06 | (0.17) | (0.04) | (0.12) | (0.43) |
Free CF/Sh
|
|||
| 0.00 | 0.65 | (2.75) | 4.92 | 6.34 | 3.72 | 3.52 | 3.61 | 2.60 | 2.36 |
Book Value/Sh
|
|||
| 100 | 100 | 19 | 77 | 63 | 106 | 107 | 100 | 103 | 101 |
Shares
|
|||
| 0.00 | 0.00 | 455.00 | 58.19 | 787.94 | 0.00 | 0.00 | 41.67 | 0.00 | 0.00 |
PE Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 5.70 | 3.51 | 1.28 | 0.85 | 0.59 | 0.43 | 1.19 |
PS Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 2.48 | 1.75 | 0.86 | 0.41 | 0.35 | 0.32 | 1.09 |
PB Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 3.26 | 1.48 | 0.26 | (0.37) | (0.28) | (0.38) | 0.60 |
EV/Sales
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 | (1.13) | (11.17) | 2.68 | (1.68) |
EV/FCF
|
|||
| (6) | 13 | 29 | 55 | 27 | 13 | (16) | 3 | (4) | (15) |
Op' Cash Flow
|
|||
| 0 | 0 | (1) | (5) | (6) | (7) | (2) | (7) | (9) | (28) |
Capex
|
|||
| (6) | 13 | 28 | 50 | 22 | 6 | (19) | (4) | (12) | (43) |
FCF
|
|||
| — | 63 | 142 | 358 | 341 | 206 | 200 | 166 | 150 | 100 |
Working Cap'
|
|||
| — | — | — | 5 | 6 | 7 | 7 | 4 | 10 | 6 |
Total Debt
|
|||
| — | (80) | (176) | (403) | (404) | (269) | (223) | (185) | (162) | (128) |
Net Debt
|
|||
| — | 66 | (52) | 380 | 398 | 395 | 378 | 361 | 268 | 239 |
Sh' Equity
|
|||
| 0.00% | (1.19%) | (7.33%) | 5.51% | 0.18% | (0.26%) | (1.93%) | 0.65% | (19.52%) | (9.20%) |
ROA
|
|||
| — | 0.00% | 0.00% | 0.00% | 0.00% | (2.53%) | (5.99%) | (3.05%) | (50.34%) | (23.16%) |
ROIC
|
|||
| 0.00% | 4.31% | 18.40% | 11.09% | 0.23% | (0.33%) | (2.46%) | 0.81% | (25.68%) | (13.67%) |
ROE
|
|||
So-Young International Inc. Sponsored ADR peers in Health Information Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| AMWL American Well Corporation | $229.1M | 0.0× | Compare |
| SPOK Spok Holdings, Inc. | $216.5M | 17.4× | Compare |
| CSLT Castlight Health, inc. | $332.4M | 0.0× | Compare |
| OPRX OptimizeRx Corp. | $148.6M | 33.4× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| DH Definitive Healthcare Corp. | $146.3M | 0.0× | Compare |
| SLP Simulations Plus, Inc. | $373.4M | 46.2× | Compare |
| LFMD LifeMD, Inc. | $140.3M | 0.0× | Compare |
| CTEV Claritev Corporation | $395.9M | 0.0× | Compare |
So-Young International Inc. Sponsored ADR (SY) key facts
- So-Young International Inc. Sponsored ADR (SY) is a Health Information Services company in the Healthcare sector, traded in the US as an ADR.
- So-Young International Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $217.8 million, up 8.41% from fiscal 2024.
- As of September 25, 2026, SY traded at $2.70, a market capitalization of $229.5 million.
- Return on equity was −13.7% and debt-to-equity 0.07.
So-Young International Inc. Sponsored ADR (SY) Latest News
2 Sep
So-Young International Inc (SY) posted record revenue in Q2 2026 earnings call. Record revenue signals strong financial results that can materially lift stock trajectory and sentiment.
31 Aug
So-Young International Inc. released Q2 earnings call highlights covering operational and financial updates for the period. Q2 earnings call highlights can moderately shift investor views on near-term results without major strategic shifts.
So-Young International Inc. Sponsored ADR released unaudited second quarter 2026 financial results. Quarterly financial results can shift near-term investor views and stock movement but rarely redefine long-term strategy.
22 May
So-Young International Inc reported a revenue surge in its Q1 2026 earnings call along with new strategic initiatives. Revenue surge and strategic updates from earnings point to major positive shifts in financial trajectory and investor sentiment.
So-Young International Inc. reported its unaudited financial results for the first quarter of 2026. Unaudited quarterly results directly reveal revenue, profit trends and operational metrics that typically drive immediate stock valuation changes.
So-Young International reported Q1 results during its earnings call, covering revenue, user metrics, profitability trends and expansion plans in the medical aesthetics sector. Q1 earnings details and management outlook typically produce moderate short-term moves in share price and sentiment without guaranteeing structural change.
25 Mar
So-Young International Inc. (SY) reported record revenue growth in Q4 2025 earnings call highlights, alongside strong performance metrics and positive outlook. Record revenue growth from Q4 2025 earnings signals major positive shift in financial trajectory and investor sentiment for SY.
So-Young International Inc. (SY) released Q4 earnings call highlights covering financial performance, strategic updates, and future outlook. Q4 earnings highlights disclose financial results, guidance, and strategies directly shaping SY's market performance and investor confidence.
So-Young International Inc. Sponsored ADR (SY) reported unaudited financial results for the fourth quarter and fiscal year 2025. Unaudited Q4 and FY 2025 financial results directly reveal performance metrics that can significantly sway investor sentiment and stock trajectory.
13 Feb
So-Young International Inc. has seen a notable increase in insider ownership, which is often a positive indicator for investors. The company is highlighted among three prominent growth firms where insider buying suggests confidence in future performance. This trend may attract more investor interest and potentially drive stock prices higher as insiders typically have better insights into the company's prospects. Increased insider ownership can positively influence investor sentiment and market performance, but its overall effect may be limited.
15 Jan
So-Young International Inc. Sponsored ADR (SY) is highlighted among three growth companies with high insider ownership, projecting earnings growth of up to 120%. The article emphasizes the potential for significant financial performance improvements driven by strong insider confidence and strategic initiatives. High insider ownership and projected earnings growth indicate significant confidence in the company's future performance.
11 Dec
High insider ownership at So-Young International Inc. is driving growth in December 2025, indicating strong confidence from executives and board members in the company's future prospects. This trend is seen as a positive signal for investors, suggesting that insiders believe in the company's potential for success and are committed to its long-term growth strategy. High insider ownership typically correlates with increased investor confidence and can significantly influence market performance.
17 Nov
So-Young International Inc. reported strong revenue growth in Q3 2025, highlighting its successful strategies and market positioning amidst competitive pressures. The company emphasized its commitment to innovation and customer satisfaction, which contributed to its financial performance. Key metrics showed an increase in user engagement and service offerings, indicating a positive outlook for future quarters. Strong revenue growth and strategic initiatives suggest significant potential for future performance and market positioning.
So-Young International Inc. reported its Q3 2025 earnings, highlighting significant growth in revenue and user engagement. The company emphasized its strategic initiatives aimed at expanding its market presence and enhancing service offerings. Management expressed optimism about future performance, driven by ongoing investments in technology and customer experience. The earnings call also addressed challenges faced in the competitive landscape and outlined plans to mitigate risks while capitalizing on emerging opportunities. Significant growth in revenue and strategic initiatives indicate a likely positive shift in the company's trajectory.
So-Young International Inc. reported its unaudited financial results for the third quarter of 2025, highlighting key metrics such as revenue, net income, and operational performance. The company experienced fluctuations in its financial figures compared to previous quarters, reflecting ongoing market conditions and strategic initiatives. Management provided insights into future growth prospects and operational adjustments aimed at enhancing profitability and market position. Fluctuations in financial figures indicate a moderately noticeable influence on the company's performance and market sentiment.
5 Nov
So-Young International Inc. Sponsored ADR (SY) is identified as being potentially undervalued, with estimates suggesting it could be up to 48.4% below its intrinsic value. Analysts highlight the company's growth potential and market position, indicating that it may present a buying opportunity for investors looking for undervalued stocks. The analysis includes comparisons with other stocks in the same sector, emphasizing the favorable outlook for So-Young amidst broader market trends. The identification of significant undervaluation suggests a moderately noticeable influence on market sentiment and potential financial performance.
So-Young International Inc. Sponsored ADR (SY) is identified as being potentially undervalued, with estimates suggesting it could be up to 46.5% below its intrinsic value. This assessment positions the stock as an attractive investment opportunity amidst current market conditions. Analysts highlight the company's growth potential and strategic initiatives that may enhance its market position. The identification of significant undervaluation suggests a moderately noticeable influence on investor sentiment and market performance.
4 Nov
So-Young International Inc. has garnered attention from insiders as a top growth stock for November 2025, indicating strong confidence in its future performance. The company is positioned to benefit from favorable market conditions and strategic initiatives that may enhance its growth trajectory. Investors are closely monitoring insider activities as a signal of potential value appreciation. Insider interest suggests significant confidence in the company's growth potential and market positioning.
9 Sep
So-Young International Inc. Sponsored ADR (SY) is highlighted as a growth stock favored by insiders for September 2025. The company is expected to benefit from strategic initiatives and market trends that align with its core operations, potentially enhancing its financial performance and competitive positioning in the industry. Significant strategic moves and market dynamics are anticipated to alter the company's trajectory.
16 Aug
So-Young International Inc. reported a significant surge in aesthetic treatment demand during Q2 2025, highlighting strong financial performance and growth in user engagement. The company emphasized its strategic initiatives to enhance service offerings and expand market presence, which contributed to improved revenue figures. Management expressed optimism about future growth prospects, driven by increasing consumer interest in aesthetic procedures and the company's innovative approaches. The surge in aesthetic treatment demand and strategic initiatives are likely to significantly impact future performance and investor sentiment.
15 Aug
So-Young International Inc. reported its unaudited financial results for the second quarter of 2025, highlighting key metrics such as revenue, net income, and operational performance. The company experienced fluctuations in its financials compared to previous quarters, reflecting ongoing market conditions and strategic initiatives. Management provided insights into future growth prospects and operational adjustments aimed at enhancing performance in the competitive landscape. Financial results indicate moderate fluctuations that may influence investor sentiment and operational strategies.
8 Aug
So-Young International Inc. has seen significant insider ownership, with stakes reaching up to 24%. This level of insider investment often indicates confidence in the company's future prospects. The article highlights So-Young alongside two other growth companies, emphasizing the potential for strong performance driven by insider commitment. Insider ownership can positively influence market sentiment and investor confidence, but its overall impact on financial performance is expected to be limited.
16 Jul
So-Young International Inc. operates a social media platform linked to the medical aesthetics industry in China, reporting significant growth in active users and verified paid visits in its 1Q25 financial release. The company achieved revenues of RMB297.3 million, beating expectations, and has seen its stock rise 411% this year. Citi analyst Nelson Cheung highlights So-Young's strong brand position and potential for further growth, rating the stock as a Buy with a price target of $5.50, suggesting a 30% gain over the next year. So-Young's rapid user growth and revenue performance indicate significant potential for future market impact and investor sentiment.
9 Jul
So-Young International Inc. Sponsored ADR (SY) is highlighted as one of three growth companies with high insider ownership and a remarkable 40% revenue growth. The article emphasizes the significance of insider ownership as a positive indicator of company health and potential for future growth. It suggests that such ownership aligns the interests of management with those of shareholders, potentially leading to better performance and strategic decisions. The focus on revenue growth further underscores the company's strong market position and operational success. High revenue growth and significant insider ownership indicate strong potential for future performance and investor confidence.
So-Young International Inc. is highlighted among high-growth tech stocks in the U.S. market, showcasing its potential for significant expansion. The company is positioned to leverage trends in the tech sector, attracting investor interest due to its innovative offerings and growth strategies. Analysts suggest that So-Young's focus on technology-driven solutions could enhance its market presence and financial performance in the coming years. So-Young's growth potential in the tech sector may moderately influence its financial performance and competitive positioning.
3 Jul
So-Young International Inc. has regained compliance with the Nasdaq minimum bid price requirement after its American Depositary Shares (ADS) closed above $1 for ten consecutive trading days. This compliance was achieved following a period of non-compliance, which could have led to delisting. The company expressed its commitment to maintaining its listing on Nasdaq and continuing to enhance shareholder value. Regaining compliance with Nasdaq requirements helps stabilize investor confidence and supports the company's market position.
30 May
So-Young International Inc. announced a plan to change the American Depositary Shares (ADS) ratio from 1 ADS representing 2 Class A ordinary shares to 1 ADS representing 10 Class A ordinary shares. This adjustment aims to enhance the liquidity of the ADS and align with the company's strategic goals. The change is expected to take effect on a specified date, and the company will provide further details to shareholders. The ADS ratio change may improve liquidity but is not expected to significantly alter the company's overall trajectory.
17 May
So-Young International Inc. reported a significant surge in aesthetic treatment demand during Q1 2025, highlighting strong financial performance and growth in user engagement. The company emphasized its strategic initiatives to enhance service offerings and expand market reach, positioning itself favorably in the competitive landscape. Management expressed optimism about future growth prospects, driven by increasing consumer interest in aesthetic procedures and ongoing investments in technology and marketing. The surge in aesthetic treatment demand and strategic initiatives are likely to significantly impact future performance and investor sentiment.
So-Young International Inc. reported Q1 2025 revenues of RMB 297.3 million, with a net loss of RMB 33.1 million, primarily due to investments in expanding aesthetic centers. The company opened 23 clinics in major cities, achieving significant revenue growth in aesthetic services. Customer satisfaction remains high, and the company plans to continue expanding its network while optimizing costs. Management expressed confidence in long-term profitability and plans to launch a franchise model to accelerate growth. The outlook for Q2 2025 anticipates aesthetic treatment revenues between RMB 120 million and RMB 140 million, reflecting a substantial year-over-year increase. Significant expansion of aesthetic centers and a shift towards a franchise model are likely to impact future performance positively.
16 May
So-Young International Inc. reported unaudited financial results for Q1 2025, with total revenues of RMB297.3 million, a 6.6% decrease from RMB318.3 million in Q1 2024. The net loss attributable to the company was RMB33.1 million, compared to a loss of RMB21.2 million in the same period last year. Operationally, the value of medical aesthetic treatment transactions fell to RMB303.2 million, while the number of verified paid visits surged to over 45,500 from approximately 4,600 in Q1 2024. The company expects aesthetic treatment services revenues for Q2 2025 to range between RMB120.0 million and RMB140.0 million, reflecting significant growth compared to the previous year. The decrease in revenues and net loss indicates challenges, but the growth in user engagement and future revenue expectations suggest moderate positive influence.